Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11120396 | 0.83 | TSHR (0.37) | ALDH1A1 | |
| SCHEMBL1141521 | 0.83 | ALDH1A1 (0.42) | ALDH1A1PTPN1CYP3A4CA2LMNA | |
| SCHEMBL14877944 | 0.83 | ALDH1A1 (0.35) | ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL13189759 | 0.82 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL14304966 | 0.82 | NQO1 (0.38) | CYP1A2 | |
| SCHEMBL21589865 | 0.81 | SMN1; SMN2 (0.36) | LMNA | |
| SCHEMBL18688555 | 0.81 | PTPN1 (0.32) | PTPN1 | |
| SCHEMBL18432046 | 0.81 | NPC1 (0.36) | ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL12168631 | 0.81 | GSTP1 (0.31) | — | |
| SCHEMBL14855871 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3170821-A1 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES | Ambrx, Inc. (US) | 2017-05-24 | — | — | EP | disclosed |
| EP-2359862-B1 | Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents | INTEZYNE TECHNOLOGIES INC (US) | 2013-07-24 | — | — | EP | disclosed |
| EP-2422781-A1 | Resistance-repellent retroviral protease inhibitors | Sequoia Pharmaceuticals, Inc. (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-1316321-B1 | BASE MATERIALS FOR TISSUE REGENERATION, TRANSPLANT MATERIALS AND PROCESS FOR PRODUCING THE SAME | JAPAN TISSUE ENG CO LTD (JP) | 2007-08-15 | — | — | EP | disclosed |